DiagnosticsCAGR7.50%
Chaple Syndrome
Market Size:USD 24.0 millionForecast Size:USD 42.80 millionForecast:2024-2032
Regions Covered:North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Major Players:Regeneron Pharmaceuticals, Inc., AstraZeneca PLC
Oct 2026220 pages$3,700